Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MCRB | CLLS | SGMT | ||
| Company | Seres Therapeutics Inc | Cellectis S.A. ADR | Sagimet Biosciences Inc Series A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.8600 | 2.37 | 4.10 | ||
| High | 0.9243 | 2.61 | 4.29 | ||
| Low | 0.8300 | 2.37 | 4.05 | ||
| Last | 0.9090 | 2.56 | 4.23 | ||
| Change | +0.0840 | +0.05 | +0.17 | ||
| % Change | +10.18% | +2.17% | +4.19% | ||
| Volume | 7,503,800 | 22,400 | 475,400 | ||
| 20-Day Average Volume | 4,831,090 | 41,805 | 412,050 | ||
| Previous Close | 0.8250 | 2.51 | 4.06 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.7045 | 2.62 | 4.64 | ||
| 20-Day Raw Stochastic | 96.02% | 40.00% | 21.51% | ||
| 20-Day Relative Strength | 57.55% | 47.54% | 42.28% | ||
| Weighted Alpha | -88.27 | -42.63 | -80.16 | ||
| Today's Opinion | 56% Sell | 16% Buy | N/A | ||
| Previous Opinion | 80% Sell | 8% Sell | N/A | ||
| Last Month's Opinion | 100% Sell | 8% Buy | N/A | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +45.53% since 04/22/24 | -3.03% since 04/22/24 | +4.96% since 04/22/24 | ||
| Low | 0.6288 on 04/23/24 | 2.35 on 04/26/24 | 3.88 on 04/26/24 | ||
| High | 0.9243 on 04/29/24 | 2.65 on 04/23/24 | 4.31 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | +17.43% since 03/28/24 | -3.40% since 03/28/24 | -21.96% since 03/28/24 | ||
| Low | 0.5400 on 04/19/24 | 2.30 on 04/18/24 | 3.83 on 04/19/24 | ||
| High | 0.9243 on 04/29/24 | 2.95 on 04/03/24 | 5.82 on 04/01/24 | ||
| 3-Month | |||||
| %Chg | -27.28% since 01/29/24 | -14.67% since 01/29/24 | -60.09% since 01/29/24 | ||
| Low | 0.5400 on 04/19/24 | 2.30 on 04/18/24 | 3.83 on 04/19/24 | ||
| High | 1.2500 on 01/30/24 | 3.13 on 02/08/24 | 11.12 on 01/31/24 | ||
| 6-Month | |||||
| %Chg | -34.13% since 10/27/23 | +153.92% since 10/27/23 | +14.02% since 10/27/23 | ||
| Low | 0.5400 on 04/19/24 | 0.96 on 10/31/23 | 2.13 on 11/13/23 | ||
| High | 2.0500 on 01/09/24 | 3.77 on 12/20/23 | 20.71 on 01/22/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 137,267 | 142,295 | 134,996 | ||
| Shares Outstanding, K | 151,009 | 55,584 | 31,914 | ||
| Annual Sales | 126,330,000 | 25,730,000 | 2,000,000 | ||
| Annual Net Income | -113,720,000 | -106,140,000 | -27,880,000 | ||
| Last Quarter Sales | 60,000 | 1,640,000 | 2,000,000 | ||
| Last Quarter Net Income | -41,250,000 | -17,480,000 | -6,360,000 | ||
| 60-Month Beta | 2.24 | 3.12 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.32 on 03/05/24 | -0.31 on 11/06/23 | -0.35 on 11/13/23 | ||
| Latest Earnings Date | 05/14/24 | 05/02/24 | 03/25/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||